...
机译:康维他汀A4的靶向肿瘤血管的脂质体递送系统:设计,表征和体外评估
Parenteral Medications Laboratories Department of Pharmaceutical Sciences University of Tennessee Health Sciences Center TN 26 S Dunlap St Room 214 38163 Memphis TN;
Parenteral Medications Laboratories Department of Pharmaceutical Sciences University of Tennessee Health Sciences Center TN 26 S Dunlap St Room 214 38163 Memphis TN;
Department of Mechanical Engineering Temple University Philadelphia PA;
Department of Mechanical Engineering Temple University Philadelphia PA;
Department of Mechanical Engineering Temple University Philadelphia PA;
Department of Pharmaceutical Sciences University of Tennessee Health Sciences Center Memphis TN;
Parenteral Medications Laboratories Department of Pharmaceutical Sciences University of Tennessee Health Sciences Center TN 26 S Dunlap St Room 214 38163 Memphis TN;
targeted liposome delivery system; combretastatin A4; tumor vasculature targeting; liposome characterization;
机译:靶向聚合胶束系统,用于将Combretastatin A4体外递送至肿瘤血管
机译:靶向聚合物胶束系统,用于在体外递送肿瘤脉管系统。
机译:Combretastatin A4的靶向脂质体递送系统:通过药物加载和体外释放研究优化配方
机译:使用VEGF靶向阿霉素脂质体靶向肿瘤血管
机译:肿瘤血管系统靶向脂质体递送系统的开发和评估,该系统用于新型抗血管药物康维他汀A4。
机译:康维他汀A4的靶向肿瘤血管的脂质体递送系统:设计表征和体外评估
机译:康维他汀A4的靶向肿瘤血管的脂质体递送系统:设计,表征和体外评估
机译:评估卵巢肿瘤血管系统的新标记以预测对治疗和治疗靶标的反应。